Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

Nature Reviews Clinical Oncology - ResearchHub

ResearchHub

Research, connected

Explore the graph

X

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Journal

Nature Reviews Clinical Oncology

1759-4774 · Springer Science and Business Media LLC

9 verified public works

Browse all journals →

Exploring the immunological effects of antibody–drug conjugates

2026 · 0 citations

Benefit with post-consolidation blinatumomab in newly diagnosed high-risk B-ALL

2026 · 0 citations

HCT–ASCT confirmed as standard-of-care consolidation therapy for PCNSL

2026 · 0 citations

Benefit from perioperative enfortumab vedotin–pembrolizumab in cisplatin-eligible MIBC

2026 · 0 citations

More options, more questions in the management of early relapsed and/or refractory multiple myeloma

2026 · 0 citations

Electronic cigarettes, smoking and lung cancer risk: some evidence about the continuum of harm

2026 · 0 citations

Does OptiTROP-Lung05 open a new frontier for first-line ADC–ICI combinations in NSCLC?

2026 · 0 citations

Second-line 177Lu-edotreotide shows promise in GEP NETs

2026 · 0 citations

Patient value over patent value: the mandate for open-source oncology

2026 · 0 citations

Page 1 of 1